4.5 Article

Application of decellularized human reticular allograft dermal matrix promotes rapid re-epithelialization in a diabetic murine excisional wound model

期刊

CYTOTHERAPY
卷 23, 期 8, 页码 672-676

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.jcyt.2020.11.009

关键词

allograft; delayed wound healing; dermis; HR-ADM; wound healing; wounds

资金

  1. MTF Biologics

向作者/读者索取更多资源

This study investigated the effects of HR-ADM application on wound closure using a diabetic murine model. The results showed that HR-ADM promoted rapid wound closure and minimized granulation tissue formation. HR-ADM also facilitated cellular infiltration, neovascularization, and collagen remodeling in the wounds.
Background aims: The treatment and care of human wounds represent an enormous burden on the medical system and patients alike. Chronic or delayed healing wounds are characterized by the inability to form proper granulation tissue, followed by deficiencies in keratinocyte migration and wound re-epithelialization, leading to increased likelihood of infection and poor wound outcomes. Human reticular acellular dermal matrix (HR-ADM) is one type of tissue graft developed to enhance closure of delayed healing wounds that has demonstrated clinical utility through accelerating closure of lower extremity diabetic ulcers, but the mechanisms underlying this clinical success are not well understood. Methods: The authors utilized a diabetic murine splinted excisional wound model to investigate the effects of HR-ADM application on wound closure. Results: The authors demonstrate that application of HR-ADM served as a dermal scaffold and promoted rapid re-epithelialization and keratinocyte proliferation, resulting in accelerated wound closure while minimizing granulation tissue formation. HR-ADM-applied wounds also demonstrated evidence of cellular infiltration, neovascularization and collagen remodeling by the host organism. Conclusions: These data suggest that HR-ADM supports epidermal closure in delayed healing wounds and remodeling of the matrix into host tissue, lending further support to the clinical success of HR-ADM described in clinical reports. (c) 2020 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据